The Simoa® Human Neurology 4-Plex E (N4PE) assay concurrently detects four biomarkers in EDTA plasma and CSF. These targets include amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament light (NfL).
The Neuro 4-Plex E kit features new amyloid beta 40 and amyloid beta 42 assays designed for highly sensitive and specific measurement of full-length amyloid beta 1-42 and amyloid beta 1-40 concentrations. This enhanced specificity for full-length amyloid beta 1-42 and amyloid beta 1-40 is anticipated to be increasingly valuable for targeting specific amyloid-beta isoforms and for target engagement in forthcoming clinical trials.
Application and intended use
The Simoa® Human Neurology 4-Plex E (N4PE) assay measures four biomarkers in EDTA plasma and CSF simultaneously. These biomarkers are known to be relevant for studying neurodegeneration and brain injury. They are also useful for monitoring the effectiveness of drug discovery and development for neurological diseases.
Compatible instruments
- Advantage Plus: HD-X
- Advantage: HD-1/HD-X
Kit contents
The assay kit contains all the essential reagents and controls needed to conduct 96 tests, ensuring ease of use and compatibility with different sample types.